Frontlight ResearchEarly access
WithdrawnNo phase
Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance
Key facts
- Who runs it
- Miracor Medical SA
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Oct 2022
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Treatments tested
- PiCSO
- Record updated
- 8 March 2023
- Why it stopped
- Study terminated due to lack of financing
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age ≥18 years old
- Culprit lesion in proximal or mid LAD
- ST-segment elevation
- Pre-PCI TIMI flow 0 or 1
- Symptoms onset time consistent with myocardial ischemia (e.g. persistent chest pain, shortness of breath, nausea/vomiting, fatigue, palpitations or syncope) ≤ 12 h
- Patient is deemed eligible for PCI
- Consent as per approved national ethical committee specific requirements prior to the procedure
Who cannot take part
- Patients with implants or foreign bodies in the coronary sinus
- Patients with previous CABG
- Known allergy to polyurethanes, PET or stainless steel
- Known pericardial effusion or cardiac tamponade
- Patients with a history of stroke, TIA or reversible ischemic neurological deficit within last 6 month
- Patients with contraindications to percutaneous insertion or angiography
- Known pregnancy or breast feeding
- Known central hemodynamically relevant left/right shunt
- Patients with symptom onset > 12 hours
- Patients with coagulopathy
- Patients under judicial protection, legal guardianship or curatorship
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A prospective, multicenter, single-arm, open label registry of commercially treated patients with PiCSO Impulse System.
The group in the trial
- PiCSO treatment group
PiCSO treatment as per IFU
Treatment: PiCSO
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 8 March 2023